A L I Technologies Ltd recalls McKesson Cardiology Hemo software
- Recall date
- December 2, 2024
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-0957-2025
- FDA classification
- Class II
- Brand / firm
- A L I Technologies Ltd
- Sold / distributed
- US Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, HI, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NE, NH, NJ, NM, NY, OH, OK, OR, PA, PA, SC, SD, TN, TX, WA, WI and the countries of Australia, Israel, Canada, Germany, Ireland, United Kingdom.
Why it was recalled
Software defect concerning autosave mechanism may result in the clinician administering incorrect medication(s).
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
McKesson Cardiology Hemo software
Get recall alerts
Free email alert whenever A L I Technologies Ltd has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: A L I Technologies Ltd